Beyond the Metal: Sustained Efficacy and Diagnostic Nuances of Bioresorbable Coronary Scaffolds

Read full text Summarise with VIRAT
Authors: Praneeth Polamuri, Anoop Agrawal
Cited by: 0
References: 2

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Bioresorbable vascular scaffolds offer temporary mechanical support and local drug delivery to coronary arteries, ultimately restoring native vessel physiology after resorption. This case describes a 62-year-old man who underwent percutaneous coronary intervention with a second-generation sirolimus-eluting MeRes100 scaffold for significant proximal left anterior descending artery stenosis. Four years post-implantation, the patient remained asymptomatic but presented with intermittent, atypical chest pain. Coronary computed tomography angiography revealed complete scaffold resorption and preserved vessel patency, though interpretation was complicated by blooming artefacts from residual metallic markers. Second-generation scaffolds like MeRes100 show improved mechanical properties, predictable bioresorption profiles, and excellent clinical outcomes, including low rates of thrombosis and restoration of vasomotion. This case highlights both the long-term safety and efficacy of MeRes100 and the limitations posed by imaging artefacts, emphasizing the need for cautious computed tomography interpretation after scaffold resorption.

Fields of Study & Subjects

Coronary Interventions and Diagnostics Cardiac Imaging and Diagnostics Antiplatelet Therapy and Cardiovascular Diseases

Publication details

Journal / source
Indian Journal of Clinical Cardiology
Volume
7
Issue
3
Pages
255–257
Publication date
21 March 2026
Language
EN